5 Best Dow Dividend Stocks To Invest In Right Now

For new investors, the key to building a portfolio is to focus first on core stocks. These are companies that are easy to understand, have a good chance to perform well over the long term, and won't keep you up at night. At Motley Fool Stock Advisor, we maintain a list of 10 core stocks to build on, including our favorite organic grocer.�

It's hard to believe that a grocery store could book investors more than 30 times their initial investment, but that's just what Whole Foods has done for those who saw the organic trend coming some 20 years ago. However, it may not be too late to participate in the long-term growth of this organic foods powerhouse. In this premium report on the company, we walk through the key must-know items for every Whole Foods investor, including the main opportunities and threats facing the company. So make sure to claim your copy today by clicking here.

Hot Industrial Conglomerate Companies To Own In Right Now: Genco Shipping & Trading Limited (GNK)

Genco Shipping & Trading Limited engages in the ocean transportation of drybulk cargoes through the ownership and operation of drybulk carrier vessels worldwide. It transports iron ore, coal, grain, steel products, and other drybulk cargoes. The company charters its vessels primarily to trading houses, which include commodities traders; producers; and government-owned entities. Its fleet consists of 53 drybulk carriers, including 9 Capesize, 8 Panamax, 17 Supramax, 6 Handymax, and 13 Handysize drybulk carriers with an aggregate carrying capacity of approximately 3,810,000 dwt. The company, through its subsidiary, Baltic Trading Limited, operates a fleet of two Capesize, four Supramax, and three Handysize drybulk carriers with an aggregate carrying capacity of approximately 672,000 dwt. Genco Shipping & Trading Limited was incorporated in 2004 and is based in New York, New York.

Advisors' Opinion:

• [By FinanceGuru]

  The second contrarian indicator is that the short interest in DryShips has increased significantly. They're topped only now by Genco Shipping (GNK), which is currently poised to be heading into bankruptcy.

5 Best Dow Dividend Stocks To Invest In Right Now: PURE Bioscience Inc.(PURE)

Pure Bioscience, Inc. engages in the discovery, development, and commercialization of bioscience products principally in the United States. The company offers silver dihydrogen citrate (SDC) based antimicrobials. The silver dihydrogen citrate technology is an electrochemical process that allows the generation of ionized silver in the presence of organic acid. It provides PURE Hard Surface, a hard surface disinfectant and food contact surface sanitizer for use in food processing equipment, machinery, and utensils; Axen30, a hard surface disinfectant; Silv�ion, an antimicrobial formulation used as a raw material in the manufacturing of personal care products; and Axenohl, an antimicrobial formulation for use as a raw material in the manufacturing of environmental protection agency-registered products. The company also offers research and development services in food processing, agriculture, water treatment, pharmaceuticals, and oil and gas projects. It sells its products t hrough partners and distributors primarily to industrial and consumer markets. The company, formerly known as Innovative Medical Services, was founded in 1992 and is headquartered in El Cajon, California.

Advisors' Opinion:

• [By Glenwoods]

  According to the global market research company Mintel, stevia-based products have increased 400% globally between 2008 and 2012, with a rise of 158% from 2011 to 2012. Stevia has grown so much in demand that the world�� largest alfalfa grower, California-based S&W Seed (SANW), began growing stevia with high glycoside yields for PureCircle (LN:PURE), the world�� largest producer of stevia, in 2011 and on roughly 250,118 acres. Now some U.S. tobacco farmers have begun to switch from growing tobacco to stevia, as tobacco sales are sliding and stevia sales are growing.

• [By Glenwoods]

  While the fermentation-based method is still in its development stages, a Malaysian company, PureCircle (LON: PURE) (OTCMKTS: PCRTF), the world�� largest producer of stevia, continues to develop its stevia through farm-based methods.� Last September PureCircle, which also has offices in Oak Brook, Ill., signed a joint agreement with the Coca-Cola Coto investigate and develop a commercially viable stevia sweetener product; and earlier this month in a press release, the two companies announced they were developing what should be a better flavor profile than the much used Reb A with rebaudioside D (Reb D) and Rebaudioside X (Reb X).� Reb D, though roughly 10% less sweet than Reb A, has a significantly lower bitterness that Reb A and has been found to have a more desirable taste profile, especially in cola products where stevia previously has not worked well.� The issue with both Reb D and Reb X is that they are found in much smaller amounts than Reb A. Thus, at this time it will take a lot more stevia leaves to produce the extracts.

5 Best Dow Dividend Stocks To Invest In Right Now: Puma Biotechnology Inc (PBYI)

Puma Biotechnology, Inc., incorporated in April 2007, is a development-stage biopharmaceutical company that acquires and develops products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. As of December 31, 2011, the Company licensed three drug candidates: PB272 (neratinib (oral)), which the Company is developing for the treatment of advanced breasts cancer patients and gastric cancer patients; PB272 (neratinib (intravenous)), which the Company is developing for the treatment of advanced cancer patients, and PB357.

PB272 (neratinib (oral))-Breast Cancer

Neratinib is a potent irreversible tyrosine kinase inhibitor, or TKI, that blocks signal transduction through the epidermal growth factor receptors (EGFRs), HER1, HER2 and HER4. The Company's initial focus is on the development of neratinib as an oral treatment of patients with HER2 positive metastatic breast cancer.

PB272 (neratinib (intravenous))

The Company develops neratinib as an intravenously administered agent. In pre-clinical studies the intravenous version of neratinib resulted in higher exposure levels of neratinib in pre-clinical models.

PB357

PB357 is an orally administered agent that is an irreversible TKI that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. PB357 is structurally similar to PB272. Pfizer completed single dose Phase I trials of PB357. The Company is evaluating PB357.

The Company competes with Genentech, GlaxoSmithKline, Roche, Boehringer Ingelheim, Takeda, Array Biopharma and Ambit Biosciences.

Advisors' Opinion:

• [By George Budwell]

  With that being said, developmental biotechs that fall hard on news could be worth taking a look at because they may have fallen for all the wrong reasons. Puma Biotechnology (NYSE: PBYI  ) , for example, plummeted by 25% about a month ago after reporting mid-stage clinical trial data for the company's flagship cancer drug PB272 (neratinib).

• [By Lee Jackson]

  Puma Biotechnology Inc. (NYSE: PBYI) is a stock that UBS views as having multiple catalysts. The analysts are positive on the potential for their cancer drug neratinib to demonstrate positive data in neoadjuvant breast, as well as specific genetic mutations for other cancers. Success in either area may lead to strong upside for the stock. The UBS price target is $61, while consensus is at $62.50.

• [By John Udovich]

  Yesterday, small cap biopharmaceutical stock Puma Biotechnology Inc (NYSE: PBYI) jumped 11.98% after announcing they will have a conference call next week to update�investors on�its clinical trials of PB272 (neratinib) in cancer patients, meaning its probably time to take a closer look at the stock to see if investor might be counting the chickens before they hatch along with the performance of large cap AbbVie Inc (NYSE: ABBV) which also recently had positive news about its own breast cancer treatment plus biotech ETFs iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).

• [By Tom Rojas and Maria Armental var popups = dojo.query(".socialByline .popC"); ]

  Puma Biotechnology Inc.(PBYI) said its investigational breast-cancer treatment showed a 33% improvement in disease-free survival over a placebo in a Phase 3 study. Share surged 271% to $218 premarket.

5 Best Dow Dividend Stocks To Invest In Right Now: Tutor Perini Corporation(TPC)

Tutor Perini Corporation, together with its subsidiaries, provides diversified general contracting, construction management, and design-build services to private clients and public agencies worldwide. It operates in three segments: Civil, Building, and Management Services. The Civil segment involves in public works construction, and the repair, replacement, and reconstruction of infrastructure. This segment?s civil contracting services include construction and rehabilitation of highways, bridges, mass transit systems, and wastewater treatment facilities. The Building segment provides services to various specialized building markets for private and public works clients, such as the hospitality and gaming, transportation, healthcare, municipal offices, sports and entertainment, education, correctional facilities, biotech, pharmaceutical, industrial and high-tech markets, electrical and mechanical, plumbing, and HVAC services. The Management Services Segment offers diversifie d construction and design-build services to the United States military and government agencies, surety companies, and multi-national corporations in the United States and internationally. This segment also provides rapid response and contract completion services; and management or general contracting services to fulfill the contractual and financial obligations of the surety on notification from the surety of a contractor bond default. The company was founded in 1894 and is headquartered in Sylmar, California.

Advisors' Opinion:

• [By Travis Hoium]

  What: Shares of construction company Tutor Perini (NYSE: TPC  ) jumped 12% today after the company released earnings.

  So what: First quarter revenue was up 9%, to $992.9 million, and earnings nearly quadrupled, to $0.31 per share. Wall Street expected revenue to be $983.2 million and earnings of just $0.24, so investors were pleasantly surprised by the results.�

• [By Rich Smith]

  On Wednesday, civil engineering firm Tutor Perini Corp. (NYSE: TPC  ) said the California High-Speed Rail Authority has identified its $985 million bid to design the initial Madera-to-Fresno segment�of California's high-speed railway as the "apparent best value" of all bids received.